Replies to post #271790 on Amarin Corp Plc (AMRN)

[Chris2125]

Rose, On the operational side, we launched Vascepa mid-quarter, received data protection for the product for eight years and had our new drug submissions for PERSERIS and Trinomia accepted for review by Health Canada. These achievements are important steps for driving our future organic growth."